Suggestions
Yusuf Sherwani
Co-Founder & CEO at Pelago (formerly Quit Genius)
Yusuf Sherwani, M.D. is the Co-Founder and CEO of Pelago, formerly known as Quit Genius.1 He is based in New York and has been leading the company since April 2017.1
Professional Background
Yusuf has a strong background in both medicine and entrepreneurship. He holds a medical degree and has experience in clinical research. Some key points about his professional journey include:
- Current Role: Co-Founder and CEO at Pelago (formerly Quit Genius) since April 20171
- Previous Experience:
Education and Achievements
Yusuf's educational background includes studying at Imperial College London.1 He has received several honors and awards for his academic and entrepreneurial achievements:
- Imperial College Business School Prize for Best Group Research Project Performance on the IBSc in Management1
- Imperial College-Santander Entrepreneurship Prize1
- Wellcome Trust Biomedical Vacation Scholarship1
These accolades highlight his excellence in both medical research and business management, which likely contributed to his success in founding and leading Pelago (Quit Genius).
Highlights
Our 2024 Annual State of Substance Use Management Trend Report reveals a clear demand for more honest dialogue about drug and alcohol use, as well as a strong desire for better support systems.
In our second iteration of this survey, we found that although more than half of workers surveyed believe employer support for substance and alcohol issues is crucial, only 14% report having access to such a benefit.
Employers have a unique opportunity to create and foster recovery-ready workplaces that reduce stigma and provide essential support and recovery resources.
By embracing comprehensive substance use management strategies, we can make significant strides in improving employee health and productivity. Read more about our findings and how you can take action in our full report, linked in the comments.
Partnering with Lumen Technologies has been incredibly inspiring.
Their commitment to destigmatizing substance use in the workplace aligns perfectly with our mission at Pelago.
The results speak for themselves: a robust 34% engagement rate in our Substance Use Management program and a significant 2.1 ROI.
More than the metrics, it's the personal stories that best highlight the impact Lumen and Pelago are making together. We've witnessed incredible transformations, like Julie’s, who completely revamped her relationship with alcohol.
It's partnerships like these that reinforce the power of collaboration and the importance of supportive, stigma-free environments.
I'm truly proud of what we've achieved together and excited for what lies ahead.
